In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

The dose is then increased to the recommended dose. If glycemic control is not achieved, it can be increased up to the maximum dose. The dose is measured in milligrams (mg ... of Ozempic as of January ...